Mounting concerns that FDA reviewers could start missing PDUFA deadlines have put many on edge. The moment calls for defensive and offensive strategies.
- Navigating CGT Biotech's Financial Headwinds And The Path Forward
- What CDMOs Wish Biotechs Knew Before Submitting An RFP
- 8 Actions To Redefine Sponsor–CDMO Relationships
- Navigating Tariffs: Implications And Strategies For Pharmaceuticals Manufacturers
- Why You Need A Raw Material Control Strategy
- Why Pharma Risk Assessments Should Include 'Working Together Alone'
- How CAR-NKs Offer Powerful Therapeutic Flexibility
- Ramping Up GMP-Compliant CAR-NK Manufacturing At Scale With iPSCs
CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Background-Free Analysis Of Mouse TILs
Syngeneic mouse tumor models are crucial for immunotherapy research, but variability in TILs and nonspecific binding complicate analysis. Discover how blocking reagents help but make the process more labor-intensive.
-
How To Facilitate Good Clinical Data Review In Your Clinical Trial
Learn how to create a system based on connectivity and automation, aggregated and usable data, flexible analysis, and methods of collaborative data review by centralizing analysis and communications.
-
Mobilizing Compliance: USP 797 And 800 Pharmacy Trailer Fleet For VA Hospitals
VA hospitals across the US are undergoing renovations to bring their facilities into compliance. The challenge was to design and manufacture a fleet of self-sufficient mobile compounding pharmacies.
-
Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)
Dive into the forefront of immune checkpoint inhibitors clinical trials with an exploration of the latest trends and key findings.
-
Optimizing Performance For De-Risked Lentiviral Vector Production
Discover a de-risked, reproducible, and scalable platform for efficient GMP manufacturing of lentiviral vectors that maximizes titers and enriches recovery through upstream and downstream optimization.
-
A Complete Macrophage Suppression Assay Workflow
Analyze an experiment conducted to validate a macrophage suppression assay workflow and demonstrate a consistent in vitro macrophage suppression assay used in the validation process.
-
High-Throughput Released N-Glycan Identification
Learn about an all-inclusive sample preparation and high-throughput glycan analysis workflow with a customizable molecule-specific glycan library.
-
Rapid And Robust Preclinical And Clinical Development Of CAR T-Cell Therapies
Streamline CAR T-cell therapy development with integrated support for asset identification, IND submission, early-phase studies, and advanced real-time tracking solutions.
-
Pioneering Gene Therapy In Rare Diseases
Overcoming barriers to gene therapy development requires continued innovation in manufacturing processes, harmonized regulatory approaches, and outcome-based pricing models.
-
Explore A High-Performing Basal Medium And Feed Pairing
A customer sought to replace a chemically defined CHO medium with a more efficient medium and feed pairing strategy in bioreactors.
NEWSLETTER ARCHIVE
- 04.24.25 -- Clinical Data Like You've Never Seen it Before
- 04.24.25 -- How Cynata Therapeutics Is Unlocking The Power Of iPSCs To Transform Regenerative Medicine
- 04.23.25 -- Enhancing Precision & Efficiency In Gene Editing Research
- 04.23.25 -- Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials
- 04.22.25 -- Unlock Advanced Resources For mAb Purification

- Navigating CGT Biotech's Financial Headwinds And The Path Forward
- How Cynata Therapeutics is Unlocking the Power of iPSCs to Transform Regenerative Medicine
- Emerging Technologies For Cell Therapy Manufacturing
- Collaboration Leads To CGT Progress At Astellas' West Coast Innovation Center
- Tessera Therapeutics Advances In Vivo Gene Therapy For SCD
CELL AND GENE CONTENT COLLECTIONS

While there are opportunities to scale, there are also manufacturing gaps, capacity issues, and production timelines that require improvement to do so. And then, of course, there’s cost. Because scale up and scale out are significant to everyone in the sector, we’ve curated insightful editorial that addresses the most important aspects of scalability.
More Content Collections